Pelthos Therapeutics Inc.

AMEX:PTHS

Biotechnology

Healthcare
$16.54 -1.28%

-$0.37 today

Market cap
$63.32M
Beta
3.13
P/E (TTM)
-0.7
EPS (TTM)
-$15.58
52W Low $16.50High $37.50

Volume 0.01M

Average 0.04M

Income Statement

Follow revenue through to earnings.

Revenue

$16.80M

FY 2025 · Annual

Operating Income

-$32.43M

FY 2025 · Annual

Net Income

-$43.32M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000016.8M
Cost of Revenue00009.37M
Gross Profit00007.43M
Gross Margin————44.2%
Research & Development209.05K391.73K2.58M1.18M1.23M
Selling, General & Admin629.95K1.93M4.28M6.39M37.08M
Operating Expenses839K2.32M6.86M7.57M39.86M
Depreciation & Amortization00002.29M
EBITDA(595.13K)(2.32M)(6.86M)(7.17M)(45.41M)
EBITDA Margin————-270.4%
Operating Income(839K)(2.32M)(6.86M)(7.57M)(32.43M)
Operating Margin————-193.1%
Interest Income00005K
Interest Expense253140.43K518.51K786.39K3.01M
Other Income / Expenses243.61K(140.43K)(518.51K)(383.89K)(18.28M)
Income Before Tax(595.39K)(2.46M)(7.38M)(7.96M)(50.71M)
Pre-Tax Margin————-301.9%
Income Tax Expense0000(7.39M)
Net Income(595.39K)(2.46M)(7.38M)(7.96M)(43.32M)
Net Margin————-257.9%
EPS (Basic)(1.00)(4.26)(12.80)(13.54)(23.04)
EPS (Diluted)(1.00)(4.26)(12.80)(13.54)(23.04)
Weighted Avg Shares576.75K576.75K576.75K587.62K1.88M
Weighted Avg Shares (Diluted)576.75K576.75K576.75K587.62K1.88M

PTHS Earnings Waterfall · TTM

AMEX:PTHS · Revenue to Net Income

Key Ratios

EPS$-40.69
Gross Margin34.3%
Net Margin-136.0%
P/E Ratio-0.9
P/S Ratio4.8

Analysis

$27.7M of revenue converted into -$51.6M of net income for the selected period. Gross margin is 34.3% and net margin is -136.0%, showing how much revenue survives after costs and taxes. EPS is $-40.69, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportMay 28, 2026
4Statement of changes in beneficial ownershipMay 26, 2026
144Notice of proposed sale of securitiesMay 22, 2026
8-KCurrent reportMay 21, 2026
4Statement of changes in beneficial ownershipMay 18, 2026

How much revenue does PTHS generate?

Pelthos Therapeutics Inc. (PTHS) reported $16.80M of revenue in fiscal 2025.

Is PTHS profitable?

Pelthos Therapeutics Inc. (PTHS) reported -$43.32M of net income, with a net margin of -257.9%.